* Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion * Deliver...
* Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully dil...
* Advanced environmental performance through renewable energy transition and enhanced carbon tran...
* Marks five consecutive years of inclusion, reflecting continued progress in ESG management and ...
* Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion * Perform...
* Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters * Marks S...
* Reinforcing long-term commitment to embedding sustainability across operations and partnerships...
* Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards...
OSLO, Norway and INCHEON, South Korea, Feb. 3, 2026 /PRNewswire/ -- The Coalition for Epidemic Prep...
* Ranked in the top one percent among more than 150,000 companies assessed globally * Recognize...
* Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion * Maintain...
* Company receives the highest Water Security rating in two years into participation * Recogniz...
* Spin-off finalized within five months following board resolution * Proposal approved in shareh...
* Recorded Q3'25 consolidated revenue of KRW 1,660.2 billion * Recorded Q3'25 consolidated opera...
* ExellenS TM applies optimized facility designs, equipment, and processes across all sites to en...
* Recorded Q2'25 consolidated revenue of KRW 1,289.9 billion * Recorded Q2'25 consolidated opera...
* Samsung Organoids to provide data-driven analysis of candidate molecules * Samsung Biologics e...
* Recorded Q1'25 consolidated revenue of KRW 1.3 trillion * Recorded Q1'25 consolidated operatin...
- Company receives leadership status and A- rating for efficient water resources management -...
* Recorded Q4'24 consolidated revenue of KRW 1.26 trillion * Recorded FY'24 consolidated reven...